UPC Analytics
ENDE
Overview · Filed:

UPC_APP_68655/2024

Procedural & sub-applicationsWithdrawal ApplicationsCourt of AppealApplication Rop 265Settled at: Post-appeal
  • 2025-01-24WithdrawnproceduralApplication Rop 265

    The Court of Appeal allowed DexCom's withdrawal of its infringement action and Abbott's withdrawal of the counterclaims for revocation, declared the proceedings closed, and ordered reimbursement of 60% of DexCom's court fees; as a result the first instance decision revoking DexCom's patent became ineffective.